Nanoparticle: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 4: | Line 4: | ||
| title = The Use of Nomenclature in Dispersion Science and Technology | | title = The Use of Nomenclature in Dispersion Science and Technology | ||
| author = Vincent A. Hackley and Chiara F. Ferraris | date = August 2001 | | author = Vincent A. Hackley and Chiara F. Ferraris | date = August 2001 | ||
| publisher = [[National Institute of | | publisher = [[National Institute of Standards and Technology]]}}, p. 4</ref> | ||
==Life sciences applications== | ==Life sciences applications== | ||
Manufactured nanoparticles can be used for drug delivery, mimicking the behavior of cellular components and acting as "intracellular reservoirs for sustained | Manufactured nanoparticles can be used for drug delivery, mimicking the behavior of cellular components and acting as "intracellular reservoirs for sustained | ||
Revision as of 20:34, 13 January 2011
In materials science, a nanoparticle is a member of a class of particles (or atomic clusters), which have average dimensions smaller than roughly 100 nm. They exhibit properties not normally associated with the bulk phase of materials, such as quantum optical effects.[1]
Life sciences applications
Manufactured nanoparticles can be used for drug delivery, mimicking the behavior of cellular components and acting as "intracellular reservoirs for sustained release of encapsulated therapeutic agent" Components include:[2]
They may be manufactured as:
- coated solid particles
- polymers
- solid lipid nanoparticles
References
- ↑ Vincent A. Hackley and Chiara F. Ferraris (August 2001), The Use of Nomenclature in Dispersion Science and Technology, National Institute of Standards and Technology, p. 4
- ↑ Pieter Stroeve, Nanotechnology in the life sciences: Life sciences and medicine, Frontis Lecture Series, pp. 26-27